Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery For Investors – Contact The Gross Law Firm
Shareholders who purchased shares of EPIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required ...
The American Journal of Managed Care3h
Getting More Doctors to Record a Life-Saving Prostate Cancer Calculation
Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...
Targeted Oncology9h
Therapeutic options for a patient with mCRPC after ADT + docetaxel
An expert discusses the therapeutic options included in the NCCN guidelines for metastatic castration-resistant prostate ...
Too Old to Operate16h
Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR ...
Investors who Lost Money on ESSA Pharma Inc. (EPIX) Should Contact Levi & Korsinsky about Pending Class Action - EPIX
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn ...